athenahealth
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict athenahealth's revenues will expand 33.3% and EPS will expand 4.5%.
The average estimate for revenue is $103.8 million. On the bottom line, the average EPS estimate is $0.23.
Revenue details
Last quarter, athenahealth logged revenue of $96.6 million. GAAP reported sales were 38% higher than the prior-year quarter's $69.9 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $0.14. GAAP EPS of $0.07 for Q1 were 22% lower than the prior-year quarter's $0.09 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 59.8%, 120 basis points worse than the prior-year quarter. Operating margin was 7.6%, 30 basis points worse than the prior-year quarter. Net margin was 2.5%, 210 basis points worse than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $429.1 million. The average EPS estimate is $0.98.
Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 186 members out of 238 rating the stock outperform, and 52 members rating it underperform. Among 60 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 44 give athenahealth a green thumbs-up, and 16 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on athenahealth is hold, with an average price target of $60.40.
- Add athenahealth to My Watchlist.